Skip to main content
Institutional deep-dive - valuation, health, statements

Financial Analysis

Filing-based analysis. Market pricing is not included. Fundamentals from SEC filings; economic data from FRED and the BLS. About our data

Fundamentals

Butterfly Network, Inc. BFLY

· Healthcare · X-Ray Apparatus & Tubes & Related Irradiation Apparatus

FY2025 10-K, filed 2026-02-27
SEC EDGAR

Filing evidence summary

Mixed evidenceCoverage 4/5 core metrics

Latest reported free cash flow was -$16M.

Backward-looking filed evidence under visible rules - not a rating, forecast or investment advice. Missing data is never scored.

Evidence signals

  • Free cash flow was negative

    Latest reported free cash flow was -$16M.

    Why this surfaced

    Free cash flow = operating cash flow minus capital expenditures; positive is supporting evidence, not a valuation conclusion. Period end 2025-12-31.

  • 4 filing risk checks flagged

    Flagged areas: Solvency & liquidity, Dilution.

    Why this surfaced

    The full financial analysis shows each value, threshold, and sector limitation.

  • Revenue expanded

    Latest reported annual revenue changed +19.0% from the prior reported annual observation.

    Why this surfaced

    Direction threshold: above +2% constructive; below -2% caution; otherwise monitor. This is not labeled one-year growth when filing periods have a gap. Period end 2025-12-31.

  • Operating margin improved

    Operating margin changed +2.2 percentage points from the prior annual period.

    Why this surfaced

    Direction threshold: more than +1 percentage point constructive; below -1 point caution. Period end 2025-12-31.

Core trend metrics

Latest annual revenue growth
+19.0%
as of 2025-12-31
Latest annual operating margin
-88.5%
as of 2025-12-31
Free cash flow
-$16M
as of 2025-12-31
ROIC snapshot
-36.0%
period varies

Hover a tile for its exact definition; the Statements tab carries per-cell filing citations.

Where to look next

Risk checks

4of 10 rule-based checks flagged
  • Solvency & liquidity
  • Dilution

Financial movement

  • Cash→ flat
  • Long-term debt→ flat
  • Inventory→ flat
  • Receivables→ flat
  • Current assets→ flat

Source & freshness

Source
SEC EDGAR XBRL
Fetched
2026-09-06
Latest period end
2025-12-31
Filings
EDGAR ↗

Reported segment mix

figures as filed · share of the filed sum · change vs the prior period in the same filing
Fiscal year ending 2025-12-3110-K filed 2026-02-27prior period 2024-12-31 from the same filingView filing
By business segment
Revenue
  • Reportable Segment$97.6M
    100.0%
    +19.0% yoy

Members sum to the consolidated $97.6M for this period.

By product or service
Revenue
  • Product$63.4M
    65.0%
    +17.1% yoy
  • Software And Other Services$34.2M
    35.0%
    +22.7% yoy

Members sum to the consolidated $97.6M for this period.

By geography
Revenue
  • United States$77.4M
    79.3%
    +22.1% yoy
  • Outside the United States$20.2M
    20.7%
    +8.3% yoy

Members sum to the consolidated $97.6M for this period.

Latest quarter
Quarter ending 2026-06-3010-Q filed 2026-07-30prior period 2025-06-30 from the same filingView filing
  • Reportable Segment$32.6M
    100.0%
    +39.5% yoy

Change is against the same quarter a year earlier, as reported in the same 10-Q.

Source: SEC DERA Financial Statement and Notes data sets. Dimensional XBRL facts on the business-segment, product/service and geographic axes; the engine keeps the accession of every figure. Descriptive and educational, not advice.

Peer percentiles

latest fiscal year ending 2025-12-31 · among 4,003 US-listed filers · 318 in Healthcare
MetricValuevs all filersvs sector
Revenue
latest fiscal-year revenue as filed
$98M
27thof 3,301
bottom third
36thof 291
middle third
Revenue growth
latest fiscal-year revenue vs the prior fiscal year
19.0%
76thof 3,137
top third
73rdof 277
top third
Gross margin
gross profit ÷ revenue
46.9%
62ndof 1,603
middle third
36thof 212
middle third
Operating margin
operating income ÷ revenue
-88.5%
17thof 2,819
bottom third
19thof 280
bottom third
Net margin
net income ÷ revenue
-79.0%
16thof 3,263
bottom third
20thof 290
bottom third
Free-cash-flow margin
(operating cash flow − |capex|) ÷ revenue
-16.4%
20thof 2,679
bottom third
31stof 261
bottom third
Return on equity
net income ÷ stockholders' equity (positive equity only)
-39.3%
21stof 3,576
bottom third
34thof 291
middle third
Stock comp ÷ revenue
stock-based compensation ÷ revenue · lower is ranked higher
24.0%
14thof 2,895
bottom third
12thof 272
bottom third
Days sales outstanding
receivables ÷ revenue × 365 · lower is ranked higher
100 days
11thof 2,398
bottom third
7thof 266
bottom third
Cash-flow accrual ratio
(net income − operating cash flow) ÷ average total assets · lower is ranked higher
-23.3%
96thof 2,278
top third
95thof 164
top third
Balance-sheet accrual ratio
change in net operating assets ÷ average net operating assets · lower is ranked higher
-55.1%
95thof 1,907
top third
92ndof 140
top third

Each filer's latest fiscal year as stored by the nightly crawl; fiscal year ends differ across the universe. A metric ranks only filers for which it is computable from filed facts. Ties split; a rank reads "better than N% of filers" in the metric's own direction. Descriptive and educational, not a rating.

Earnings quality

latest fiscal year ending 2025-12-31 · accruals and cash conversion as filed
Cash conversion
-
operating cash flow ÷ net income, latest fiscal year
Cash-flow accrual ratio
-23.3%
(net income − operating cash flow) ÷ average total assets
Balance-sheet accrual ratio
-55.1%
change in net operating assets ÷ average net operating assets
Cash-backed years
3 of 5
fiscal years where operating cash flow met or exceeded net income
Mean cash conversion
-
across the stored fiscal years with positive net income

Per fiscal year from filed facts: cash conversion = operating cash flow / net income (net income > 0); cash-flow accrual ratio = (net income - operating cash flow) / average total assets; balance-sheet accrual ratio = change in net operating assets / average net operating assets, NOA = (assets - cash) - (liabilities - debt). Descriptive; a missing input yields a missing ratio. High accrual ratios and cash conversion well below one are the measures the accruals literature associates with less persistent earnings; they are screens to read the cash-flow statement with, not conclusions. The per-year series is part of Pro risk analysis.

Point-in-time ledger

first-reported vs latest filing · periods since 2020-01-01 · 13 changed periods
Line itemPeriodFirst reportedLatest filingChangeFilings
Stockholders' equity
StockholdersEquity
balance at 2020-03-31$24K
10-Q 2020-08-14
-$234M
10-Q/A 2022-03-28
-974187.5%first · latest · 6 filings carry it
Net income
NetIncomeLoss
quarter 2020-06-30-$63.1K
10-Q 2020-08-14
-$23.2M
10-Q/A 2022-03-28
-36732.6%first · latest · 4 filings carry it
Net income
NetIncomeLoss
quarter 2020-09-30-$327K
10-Q 2020-11-16
-$92.2M
10-Q/A 2022-03-28
-28095.1%first · latest · 3 filings carry it
Operating income
OperatingIncomeLoss
quarter 2020-09-30-$463K
10-Q 2020-11-16
-$91.8M
10-Q/A 2022-03-28
-19737.3%first · latest · 4 filings carry it
Operating income
OperatingIncomeLoss
quarter 2020-06-30-$120K
10-Q 2020-08-14
-$23.1M
10-Q/A 2022-03-28
-19089.2%first · latest · 4 filings carry it
Stockholders' equity
StockholdersEquity
balance at 2020-12-31$5M
10-K 2021-03-29
-$362M
10-K 2024-03-04
-7338.6%first · latest · 15 filings carry it
Stockholders' equity
StockholdersEquity
balance at 2020-09-30$5M
10-Q 2020-11-16
-$344M
10-Q/A 2022-03-28
-6977.9%first · latest · 4 filings carry it
Stockholders' equity
StockholdersEquity
balance at 2020-06-30$5M
10-Q 2020-08-14
-$254M
10-Q/A 2022-03-28
-5185.2%first · latest · 7 filings carry it
Total liabilities
Liabilities
balance at 2020-12-31$17.3M
10-K 2021-03-29
$148M
10-Q/A 2022-03-28
+756.9%first · latest · 10 filings carry it
Total liabilities
Liabilities
balance at 2020-09-30$14.8M
10-Q 2020-11-16
$34.8M
10-K/A 2021-05-12
+135.4%first · latest
Total liabilities
Liabilities
balance at 2020-06-30$14.6M
10-Q 2020-08-14
$26.7M
10-K/A 2021-05-12
+83.7%first · latest
Total assets
Assets
balance at 2020-12-31$415M
10-K 2021-03-29
$147M
10-Q/A 2022-03-28
-64.5%first · latest · 10 filings carry it
Depreciation and amortization
DepreciationDepletionAndAmortization
fiscal year 2022-12-31$5.93M
10-K 2023-03-23
$5.9M
10-K 2025-02-28
-0.6%first · latest · 3 filings carry it

First filing reporting each period vs the latest filing carrying it (10-K and 10-Q only, periods since 2020, the extractor's winning tag per concept); a change under 0.5% is treated as rounding. A change can be a restatement, a reclassification or a re-tagging in a later comparative column; the two filings are linked so the reader can see which. Descriptive, not a verdict.

Notes by disclosure type

debt, leases, revenue, segments, contingencies, taxes and more · the filer's own words
Latest quarterly report10-Q FY2026 Q2 · filed 20260730View filing
Commitments and contingencies · 8,942 characters as filed

"Commitments and Contingencies Commitments Leases: The Company primarily enters into leases for office space that are classified as operating leases. For the three months ended June 30, 2026 and 2025, total lease cost was $0.7 million and $0.7 million, respectively. For the six months ended June 30, 2026 and 2025, total lease cost was $1.5 million and $1.4 million, respectively. Total lease cost was primarily composed of operating lease costs. Purchase Commitments: The Company enters into inventory purchase commitments with third-party manufacturers in the ordinary course of business, including a non-cancellable inventory supply agreement with a certain third-party manufacturing vendor. The provisions of the agreement allowed the Company, once it reached a certain cumulative purchase threshold in the fourth quarter of 2021, to pay for a portion of the subsequent inventory purchases using an advance previously paid to the vendor. As of June 30, 2026, the aggregate amount of minimum inventory purchase commitments is $2.0 million, and the Company has a vendor advance asset of $0.4 million, net of write-downs, and an accrued purchase commitment liability of $0.1 million related to the agreement. The portion of the balances that is expected to be utilized in the next 12 months is included in current assets and current liabilities in the accompanying condensed consolidated balance sheets. The Company applied the guidance in Accounting Standards Codification Topic 330, Inventory to

CommitmentsAndContingenciesDisclosureTextBlock · excerpt; the full note is in the filing

Revenue disaggregation · 697 characters as filed

The following table summarizes the Companys disaggregated revenue (in thousands): Pattern of Recognition Three months ended June 30, Six months ended June 30, 2026 2025 2026 2025 By type of good or service: Product Point-in-time $ 15,720 $ 16,621 $ 30,373 $ 30,785 Software and other services Over time 16,892 6,762 28,769 13,823 Total revenue $ 32,612 $ 23,383 $ 59,142 $ 44,608 By geographical market: United States $ 27,591 $ 17,540 $ 48,954 $ 34,579 International 5,021 5,843 10,188 10,029 Total revenue $ 32,612 $ 23,383 $ 59,142 $ 44,608 By business line: Core business $ 21,851 $ 21,387 $ 42,646 $ 40,303 Embedded 10,761 1,996 16,496 4,305 Total revenue $ 32,612 $ 23,383 $ 59,142 $ 44,608

DisaggregationOfRevenueTableTextBlock · excerpt; the full note is in the filing

Share-based compensation · 3,494 characters as filed

"Stock-Based Compensation Equity Incentive Plans For the three and six months ended June 30, 2026, there were no significant changes to the Companys 2012 Employee, Director and Consultant Equity Incentive Plan, as amended, (the ""2012 Plan"") and the Companys Amended and Restated 2020 Equity Incentive Plan (the ""2020 Plan""). On January 1, 2026, pursuant to the terms of the 2020 Plan, the number of shares reserved for issuance was increased automatically by 4% of the number of outstanding shares of common stock as of January 1, 2026. Stock Option Activity The following table summarizes the changes in the Companys outstanding stock options: Number of Options Outstanding at December 31, 2025 5,551,227 Granted Exercised (1,662,938) Forfeited (1,706,317) Outstanding at June 30, 2026 2,181,972 Generally, each award vests based on continued service per the award agreement. The grant date fair value of the award is recognized as stock-based compensation expense over the requisite service period. The grant date fair value was determined using similar methods and assumptions as those previously disclosed by the Company. Restricted Stock Unit Activity The following table summarizes the changes in the Companys outstanding restricted stock units (""RSUs""): Number of RSUs Outstanding at December 31, 2025 21,538,563 Granted 8,016,481 Vested (7,704,480) Forfeited (1,649,105) Outstanding at June 30, 2026 20,201,459 Generally, each award vests based on continued service per the award agreem

DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock · excerpt; the full note is in the filing

Fair value · 3,707 characters as filed

"Fair Value of Financial Instruments Fair value estimates of financial instruments are made at a specific point in time, based on relevant information about financial markets and specific financial instruments. As these estimates are subjective in nature, involving uncertainties and matters of significant judgment, they cannot be determined with precision. Changes in assumptions can significantly affect estimated fair value. The Company measures fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The Company utilizes a three-tier hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value: Level 1 Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access. Level 2 Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities. Level 3 Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The Company has no assets or liabilities valued with Level 3 inputs. The carrying values of cash and cash equivalents, accounts re

FairValueDisclosuresTextBlock · excerpt; the full note is in the filing

New accounting pronouncements · 2,054 characters as filed

"Recent Accounting Pronouncements Issued but Not Yet Adopted The Company considers the applicability and impact of all Accounting Standards Updates (""ASUs"") issued by the Financial Accounting Standards Board (""FASB""). ASUs not listed below were assessed and determined to be either not applicable or are expected to have minimal impact on the Companys consolidated financial statements. In November 2024, the FASB issued ASU 2024-03, Income StatementReporting Comprehensive IncomeExpense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses , which introduced new guidance on disclosures of specified information about certain costs and expenses included within expenses presented on the face of the income statements, such as purchases of inventory and employee compensation. This guidance is effective for the Company for annual reporting periods beginning January 1, 2027 and interim reporting periods beginning January 1, 2028. The Company is currently evaluating the impact that the adoption of this pronouncement will have on the Company's consolidated financial statements and disclosures. In September 2025, the FASB issued ASU 2025-06, IntangiblesGoodwill and OtherInternal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software , which introduced new guidance to modernize the accounting for internal-use software development costs by removing references to prescriptive and sequential software development

NewAccountingPronouncementsPolicyPolicyTextBlock · excerpt; the full note is in the filing

Revenue recognition · 2,515 characters as filed

Revenue Recognition Disaggregation of Revenue The Company disaggregates revenue from contracts with customers by type of good or service, geographical market, and business line. For the business line disaggregation, the Company considers revenue from its core business to be all revenue generated by activities outside of its Embedded business line. The Company believes that these categories aggregate the payor types by nature, amount, timing, and uncertainty of its revenue streams. The following table summarizes the Companys disaggregated revenue (in thousands): Pattern of Recognition Three months ended June 30, Six months ended June 30, 2026 2025 2026 2025 By type of good or service: Product Point-in-time $ 15,720 $ 16,621 $ 30,373 $ 30,785 Software and other services Over time 16,892 6,762 28,769 13,823 Total revenue $ 32,612 $ 23,383 $ 59,142 $ 44,608 By geographical market: United States $ 27,591 $ 17,540 $ 48,954 $ 34,579 International 5,021 5,843 10,188 10,029 Total revenue $ 32,612 $ 23,383 $ 59,142 $ 44,608 By business line: Core business $ 21,851 $ 21,387 $ 42,646 $ 40,303 Embedded 10,761 1,996 16,496 4,305 Total revenue $ 32,612 $ 23,383 $ 59,142 $ 44,608 Contract Balances Contract balances represent amounts presented in the condensed consolidated balance sheets when the Company has either transferred goods or services to the customer or the customer has paid consideration to the Company under the contract. These contract balances include trade accounts receivable an

RevenueFromContractWithCustomerTextBlock · excerpt; the full note is in the filing

Significant accounting policies · 10,544 characters as filed

"Summary of Significant Accounting Policies Basis of Presentation and Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries and have been prepared in accordance with generally accepted accounting principles in the U.S. (""U.S. GAAP"") and the accounting disclosure rules and regulations of the SEC regarding interim financial reporting. Certain information and note disclosures normally included in the annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. Therefore, these condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes included in the 2025 Annual Report on Form 10-K. All intercompany balances and transactions are eliminated upon consolidation. The condensed consolidated balance sheet as of December 31, 2025, included herein, was derived from the audited consolidated financial statements as of that date but does not include all disclosures, including certain notes, required by U.S. GAAP for annual reporting. In the opinion of management, the accompanying condensed consolidated financial statements reflect all normal and recurring adjustments necessary to present fairly the financial position, results of operations, and cash flows for the interim periods. The results for the three and six months ended June 30, 2026 are

SignificantAccountingPoliciesTextBlock · excerpt; the full note is in the filing

Source: SEC DERA Financial Statement and Notes data sets (txt.tsv), excerpts of the filer's own note text; the full note is in the linked filing. Excerpts are the first part of each note exactly as tagged in the filing; open the filing for the full text and the tables. Descriptive and educational, not advice.

Fundamentals from SEC EDGAR. Scores, the DCF, and every model shown are educational analysis, not investment advice or price predictions.

Educational content only. Not financial advice. TrendNalysis provides educational and informational financial analysis built from public SEC filings and economic data (FRED, BLS). It is not financial, investment, tax, or legal advice and is not a recommendation to buy or sell any security. Market pricing is not currently included. Past performance does not guarantee future results. Always do your own research and consult a licensed financial professional before investing.